Puma Biotechnology reported $29.47M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 763.03M 47.8M
Agios Pharmaceuticals AGIO:US $ 1721.82M 574.81M
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
Alnylam Pharmaceuticals ALNY:US $ 853.36M 72.83M
Amgen AMGN:US $ 8247M 1087M
Arena Pharmaceuticals ARNA:US $ 971.08M 114.91M
Array Technologies Inc ARRY:US -68609000 1.51M
Biogen BIIB:US $ 10429.9M 322M
Biomarin Pharmaceutical BMRN:US $ 4241.57M 79.56M
Bluebird Bio BLUE:US $ 984.56M 215.77M
Cerulean Pharma CERU:US $ 7.74M 4.49M
Clovis Oncology CLVS:US $ -206.98M 14.06M
Daiichi Sankyo 4568:JP Y 1280098M 8045M
Esperion Therapeutics ESPR:US $ -304310000 34.92M
Exelixis EXEL:US $ 2043.08M 131.89M
Gilead Sciences GILD:US $ 19710M 758M
Glaxosmithkline GSK:US $ 15377M 512M
Intercept Pharmaceuticals ICPT:US $ -203.2M 3.2M
Macrogenics MGNX:US $ 319.04M 31.49M
Mirati Therapeutics MRTX:US $ 1128.92M 130.49M
Moderna Inc MRNA:US 6.7B 2.87B
Novartis NOVN:VX SF 54042M 3519M
Ptc Therapeutics PTCT:US $ 196.58M 96M
Puma Biotechnology PBYI:US $ 29.47M 13.03M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Sangamo Biosciences SGMO:US $ 445.46M 24.9M
Sarepta Therapeutics SRPT:US $ 485.11M 50.34M
Seattle Genetics SGEN:US $ 3391.27M 33.35M
Spectrum Pharmaceuticals SPPI:US $ 108.59M 13.85M
Takeda 4502:JP Y 5299774M 126737M
Tg Therapeutics TGTX:US $ 383.13M 62.16M
Ultragenyx Pharmaceutical RARE:US $ 972.17M 82.41M
Vanda Pharmaceuticals VNDA:US $ 481.22M 13.59M
Vertex Pharmaceuticals VRTX:US $ 9196.4M 216.14M
YTE INCY:US $ 2935.86M 208.02M